CMMBVSGTBP• 12 Months (Normalized)
CMMB vs GTBP (Chemomab Therapeutics Ltd. vs GT Biopharma Inc.)
Showing Closing Date Range from Sep 29, 2025 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CMMB Performance $1.67
-36.98%
Chemomab Therapeutics Ltd.
Normalized Baseline0.00%
GTBP Performance $7.1
+%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-36.98 pts
GTBP outperforming by 36.98 percentage points
CMMBGTBP
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CMMB GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | CMMB Price | CMMB Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $1.67 | -36.98% | $- | - | |
| Sep 28, 2026 | $1.64 | -38.11% | $- | - | |
| Sep 25, 2026 | $2.16 | -18.49% | $- | - | |
| Sep 24, 2026 | $2.20 | -16.98% | $- | - | |
| Sep 23, 2026 | $2.28 | -13.96% | $7.10 | +1124.14% | -1138.10% |
| Sep 22, 2026 | $2.51 | -5.28% | $- | - | |
| Sep 21, 2026 | $2.48 | -6.42% | $7.18 | +1137.93% | -1144.35% |
| Sep 18, 2026 | $2.61 | -1.51% | $7.16 | +1134.48% | -1135.99% |
| Sep 17, 2026 | $2.80 | +5.66% | $7.49 | +1191.38% | -1185.72% |
| Sep 16, 2026 | $2.65 | +0.00% | $7.81 | +1246.55% | -1246.55% |
| Sep 15, 2026 | $2.47 | -6.79% | $9.00 | +1451.72% | -1458.51% |
| Sep 14, 2026 | $2.45 | -7.55% | $11.63 | +1905.17% | -1912.72% |
| Sep 11, 2026 | $2.58 | -2.64% | $8.61 | +1384.48% | -1387.12% |
| Sep 10, 2026 | $2.60 | -1.89% | $6.18 | +965.52% | -967.41% |
| Sep 09, 2026 | $2.69 | +1.51% | $5.98 | +931.03% | -929.52% |
Page 1 of 17